Ascend Wellness Holdings (AAWH) Inventory Average (2021 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Inventory Average of $85.9 million for Q1 2026, down 1.88% year-over-year from $87.6 million in Q1 2025, and up 2.67% quarter-over-quarter from $83.7 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Inventory Average (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $85.9 million for Q1 2026.
- In Q1 2026, Inventory Average fell 1.88% year-over-year to $85.9 million; the TTM figure through Mar 2026 stood at $85.9 million (down 1.88% YoY), while the FY2025 annual figure was $87.1 million, down 5.73% from the prior year.
- Inventory Average for Q1 2026 stood at $85.9 million, up from $83.7 million in the prior quarter.
- The five-year high for Inventory Average was $105.3 million in Q2 2024, with the low at $71.9 million in Q1 2022.
- The 5-year median for Inventory Average is $89.8 million (2022), against an average of $90.4 million.
- The sharpest annual moves came in 2022 and 2025: Inventory Average jumped 112.7% in 2022, then declined 20.29% in 2025.
- Ascend Wellness Holdings' Inventory Average stood at $94.8 million in 2022, then dropped by 2.75% to $92.2 million in 2023, then increased by 1.38% to $93.5 million in 2024, then retreated by 10.46% to $83.7 million in 2025, then rose by 2.67% to $85.9 million in 2026.
- Business Quant data shows AAWH's Inventory Average at $85.9 million in Q1 2026, $83.7 million in Q4 2025, and $82.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 1.41 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.20 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 2.56 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.99 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 186.05 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 84.35 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.74 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 824.00 Mn |
| 10 | Ascend Wellness Holdings | 83.23 Mn | 16.23 Mn | 45.49 Mn | 84.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 84.71 Mn |
| Mar 31, 2026 | 85.93 Mn |
| Dec 31, 2025 | 83.69 Mn |
| Sep 30, 2025 | 82.50 Mn |
| Jun 30, 2025 | 83.95 Mn |
| Mar 31, 2025 | 87.57 Mn |
| Dec 31, 2024 | 93.47 Mn |
| Sep 30, 2024 | 100.61 Mn |
| Jun 30, 2024 | 105.32 Mn |
| Mar 31, 2024 | 101.06 Mn |
| Dec 31, 2023 | 92.19 Mn |
| Sep 30, 2023 | 89.32 Mn |
| Jun 30, 2023 | 93.96 Mn |
| Mar 31, 2023 | 97.95 Mn |
| Dec 31, 2022 | 94.80 Mn |
| Sep 30, 2022 | 89.78 Mn |
| Jun 30, 2022 | 82.86 Mn |
| Mar 31, 2022 | 71.91 Mn |
| Dec 31, 2021 | 60.80 Mn |
| Sep 30, 2021 | 51.55 Mn |